Local consolidative therapy for synchronous oligometastatic non‐small cell lung cancer treated with first‐line pembrolizumab: A retrospective observational study

BACKGROUND: Local consolidative therapy (LCT) has emerged as a treatment option in patients with oligometastatic non‐small cell lung cancer (NSCLC) undergoing chemotherapy or targeted therapy. However, the current literature lacks evidence as to whether LCT improves survival in NSCLC patients receiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ya, Wang, Yanan, Yang, Zhengyu, Hu, Minjuan, Lu, Jun, Zhang, Yanwei, Qian, Fangfei, Zhang, Bo, Wang, Shuyuan, Wang, Kai, Zhang, Wei, Han, Baohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888157/
https://www.ncbi.nlm.nih.gov/pubmed/35060346
http://dx.doi.org/10.1111/1759-7714.14312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888157/
https://www.ncbi.nlm.nih.gov/pubmed/35060346
http://dx.doi.org/10.1111/1759-7714.14312

Ejemplares similares